CLS Holdings USA Engages Hayden IR to Develop Comprehensive Investor Relations Program

Focused on Increasing Awareness and Enhancing Shareholder Value

BOULDER, CO / ACCESSWIRE / June 29, 2015 / CLS Holdings USA, Inc. (OTC Markets: CLSH), a diversified cannabis company, today announced that it has retained Hayden IR. Hayden IR is a fifteen-year old, highly-recognized national investor relations firm that will raise CLS Holdings USA’s visibility and strengthen its relationships with the investment community, increase awareness and enhance shareholder value.

CLS Holdings USA business model includes licensing operations, processing revenue, processing facilities, sale of products and brand creation and consulting services. CLS stands for “Cannabis Life Sciences,” as it maintains a proprietary method of extracting various cannabinoids from the marijuana plant and converting them into higher quality and quantity. The Company mission is to be the industry leader in the extraction, conversion and marketing of cannabinoid oils, wax, edibles and shatter by leveraging our extraction methods and conversion processes.

“Over the past year, our CLS Holdings USA team has successfully taken a vision, implemented a business plan and created an infrastructure in the rapidly moving legalized cannabis industry. Our company is entering a very exciting phase as we look to commercialize our proprietary methods in a compliant, tested and standardized environment. We are excited by our progress to-date as we look to take advantage of the emerging legalized cannabis industry in which the market is projected to grow annually by 27% over the next three years to an expected market value greater than $8B by the end of 2018,” said Jeff Binder, CLS Holdings USA’s Chairman, President and Chief Executive Officer. “We believe it is an appropriate time to retain a national investor relations firm to help us target and expand our investor audience and ensure we are communicating effectively with Wall Street. We look forward to working with the team of professionals at Hayden IR to execute this important goal.”

With offices in New York, Phoenix, Minneapolis and San Diego, Hayden IR provides a comprehensive range of investor relations services. Hayden IR connects emerging growth companies with institutions, independent portfolio managers, buy-side and sell-side analysts, family offices, retail brokerage firms and accredited individual investors though a comprehensive, multi-tier proactive program. Hayden delivers expertise and professionalism in such areas as investor management, relationship building, awareness campaigns, online presence and corporate identity.

Brett Maas, Managing Partner at Hayden IR, added, “We are very excited to be working with CLS Holdings USA, a company with experienced management, proprietary methodology and strong relationships in the burgeoning regulated cannabis industry. Its business model, partnerships and industry relationships make CLS Holdings USA well positioned to take advantage of the expected growth of regulated cannabis over the next few years. The team at Hayden IR looks forward to articulating this opportunity to the professional investment community.”

About CLS Holdings USA, Inc.

CLS Holdings USA, Inc. is a diversified cannabis company, specializing in the extraction and conversion of cannabinoids. CLS stands for “Cannabis Life Sciences,” as it maintains a proprietary method of extracting various cannabinoids from the marijuana plant and converting them into higher quality and quantity. CLS Holdings USA business model includes licensing operations, processing revenue, processing facilities, sale of products and brand creation and consulting services.

For more information, check out: http://www.clsholdingsinc.com

Forward-Looking Statements

Forward-Looking Statements. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Form 8-K filed on April 30, 2015, including but not limited to the discussion under “Risk Factors” therein, which the Company has filed with the SEC and which may be viewed at http://www.sec.gov.

Contact Information

Corporate:
Chairman and CEO
Jeff Binder
jeff@clsholdingsinc.com
888-438-9132

Investors:
Hayden IR
Brett Maas
brett@haydenir.com
646-536-7331

SOURCE: CLS Holdings USA, Inc.

ReleaseID: 430228